Dow Up 0.15% Nasdaq Up 0.21%

OncoMed Pharmaceuticals, Inc. (OMED)

-NasdaqGS
18.82 Up 0.82(4.56%) 4:00PM EDT
Prev Close:18.00
Open:18.06
Bid:18.15 x 100
Ask:19.20 x 400
1y Target Est:43.20
Beta:1.637
Next Earnings Date:N/A
Day's Range:17.80 - 19.17
52wk Range:12.07 - 42.34
Volume:178,447
Avg Vol (3m):181,289
Market Cap:560.08M
P/E (ttm):N/A
EPS (ttm):-1.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMEDUp 4.56%560.08M
STMLUp 1.45%180.73M
VSTMUp 4.94%241.62M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback